Alexandre Karras

Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies

Aude Servais, Laure‐Hélène Noël, Lubka T. Roumenina et al. · Kidney International · 2012 · 567 citations

Medicine, Immunology, Nephrology +17

Tenofovir‐Related Nephrotoxicity in Human Immunodeficiency Virus–Infected Patients: Three Cases of Renal Failure, Fanconi Syndrome, and Nephrogenic Diabetes Insipidus

Alexandre Karras, Matthieu Lafaurie, André Furco et al. · Clinical Infectious Diseases · 2003 · 363 citations · Full text

Medicine, Infectious Diseases, Nephrology +14

Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)

Pierre Charles, Benjamin Terrier, Élodie Perrodeau et al. · Annals of the Rheumatic Diseases · 2018 · 336 citations

Life Sciences, Immunology, Pharmacotherapy +15

<i>INF2</i>Mutations in Charcot–Marie–Tooth Disease with Glomerulopathy

Olivia Boyer, Fabien Névo, Emmanuelle Plaisier et al. · New England Journal of Medicine · 2011 · 284 citations · Full text

Medicine, Molecular Genetics, Neurology +15

Rituximab plus Peg-interferon-α/ribavirin compared with Peg-interferon-α/ribavirin in hepatitis C–related mixed cryoglobulinemia

David Saadoun, Matthieu Resche‐Rigon, D. Sène et al. · Blood · 2010 · 262 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +12